Medical News

RSS

Exercise can ease arthritis pain

People with arthritis who exercise have less pain, more energy, improved sleep, and better day-to-day function, according to the American College of Rheumatology.

16 Aug 2010

Survey: Majority of U.S. pharmaceutical companies develop drugs for mental illness

Pharmaceutical research and biotechnology companies in New Jersey, California, New York and North Carolina are responsible for 192 of the 313 medicines in development today to treat mental illnesses, a new survey shows.

16 Aug 2010

Clinical trials activity of Synexus in Hungary increases 25% in first-half of 2010

Synexus clinical trials activity in Hungary has increased by 25% during the first half of 2010. The company's Dedicated Research Centre has been operating in Hungary since 2006 and has become one of the company's most successful CEE sites. The Budapest-based operation has been involved in excess of 74 trials since being acquired by Synexus, and randomized over 600 patients.

From AES - Accelerated Enrollment Solutions 16 Aug 2010

CTI announces EMEA's validation of expanded PIP for pixantrone

Cell Therapeutics, Inc. announced today that it has received notice that the European Medicines Agency has validated the expanded Pediatric Investigation Plan that CTI filed in July for pixantrone for the treatment of relapsed or refractory, aggressive non-Hodgkin's lymphoma (NHL).

16 Aug 2010

R-Tech Ueno, Sucampo Pharmaceuticals request arbitration against Takeda Pharmaceutical

R-Tech Ueno supplies Amitiza (TM) Capsules to Takeda pursuant to agreements with Takeda and Sucampo. On March 12, 2010, Sucampo submitted for filing with the International Court of Arbitration, International Chamber of Commerce, a Request for Arbitration against Takeda. In that Request, Sucampo claimed that Takeda has violated the provisions of the October 29, 2004, Collaboration and License Agreement between Sucampo and Takeda and other applicable duties, and that Takeda's violations have injured Sucampo. Sucampo requested all appropriate relief, including termination of the agreements, damages remedy and so on.

16 Aug 2010

China Medical Technologies first-quarter fiscal 2010 revenues decrease 10.9% to RMB186.2 million

China Medical Technologies, Inc., a leading China-based advanced in-vitro diagnostic company, today announced its unaudited financial results for the first fiscal quarter ended June 30, 2010.

16 Aug 2010

Washington Hospital's Stroke Program receives Gold Plus Performance Achievement Award

In just a few short years since its inception, Washington Hospital's Stroke Program has earned top honors - The Gold Plus Performance Achievement Award - which is part of the American Heart Association (AHA) and American Stroke Association (ASA)'s Get With The Guidelines(GWTG) program, a national evidence-based initiative to improve stroke patients' outcomes.

16 Aug 2010

Obama reschedules meeting with state insurance regulators

Just a day after announcing that President Barack Obama would meet with state insurance regulators in Seattle next week, the White House said Friday that the meeting would have to come later.

16 Aug 2010

SAS and EHFCN collaborate to promote awareness on healthcare fraud

SAS, the leader in business analytics software and services, will collaborate with the European Healthcare Fraud and Corruption Network (EHFCN) to spread information about detecting and preventing health care fraud. The collaboration will expose Belgium-based EHFCN to a broader European audience and identify SAS and the SAS® Fraud Framework for Health Care as a "privileged technical resource" for health care providers and insurers.

16 Aug 2010

Menopause is not the end of women's love life

Menopause doesn't have to signal the end of a woman's love life. In fact, most women can enjoy even better sex after their reproductive years if they follow some healthy advice. Sex is good exercise and slows the aging process, so it's not only permissible but also smart to keep it a central part of one's lifestyle.

16 Aug 2010

Northstar Healthcare second-quarter net patient service revenue decreases to $4.4 million

Northstar Healthcare Inc. today announced its financial results for the second quarter and six months ended June 30, 2010.

16 Aug 2010

Scientists identify genes associated with aggressive breast cancer

Researchers at the University of Gothenburg, Sweden, have for the first time identified 12 genes that could be associated with aggressive breast tumours. The discovery could result in more reliable prognoses and better treatment strategies for patients.

16 Aug 2010

Opinions: PEPFAR funding; Aid in Africa; Obama, human rights

Following a recent letter by Sen. Richard Lugar (R-Ind.) to President Barack Obama that "expressed concern about the future of" PEPFAR "as details of the Obama administration's Global Health Initiative emerge," a Courier-Journal editorial looks at how the "U.S. made a commitment to be a major player in the worldwide fight against AIDS" and details how "arguably the most successful program implemented by President Bush" has made huge strides in broadening HIV treatment access and preventing mother-to-child-transmission in the developing world.

16 Aug 2010

Abnormalities in certain genes may cause autism: Research

Together with colleagues from an international research group, autism researcher Christopher Gillberg of the University of Gothenburg, Sweden, has found in a new study that autism can be partially explained by abnormalities in certain genes. The group's results could, in the long run, pave the way for more appropriate treatments for autism.

16 Aug 2010

Watson to launch ella emergency contraceptive in fourth-quarter 2010

Watson Pharmaceuticals, Inc., today announced that it intends to launch ella® (ulipristal acetate), a novel oral emergency contraceptive, in the fourth quarter of 2010. Watson's announcement follows the approval of ella® by the FDA as safe and effective in preventing unintended pregnancy for up to 120 hours – or five days – post-unprotected intercourse (UPI) or contraceptive failure.

16 Aug 2010

Researchers pace embryonic heart with laser

Scientists at Case Western Reserve University and Vanderbilt University found that pulsed light can pace contractions in an avian embryonic heart, with no apparent damage to the tissue. The work, "Optical pacing of the embryonic heart," will be published in the advanced online issue of Nature Photonics on Aug. 15, 2010.According to the scientists, this non-invasive device may prove an effective tool in understanding how environmental factors that alter an embryo's heart rate lead to congenital defects. It may also lead to investigations of cardiac electrophysiology at the cellular, tissue and organ levels, and possibly the development of a new generation of pacemakers.

16 Aug 2010

US WorldMeds announces acquisition of Solstice Neurosciences for $35M

US WorldMeds, LLC, a Kentucky-based specialty pharmaceutical company that develops unique products to address unmet medical needs, today announced it has acquired Solstice Neurosciences, Inc. for $35 million. The acquisition expands US WorldMeds' operations, adds to the company's growing portfolio of products and enhances the company's ability to create and deliver high-quality specialty pharmaceutical products to its targeted global markets.

16 Aug 2010

Delegates explore agricultural cooperation, expanded ties at two-day China-Africa Agricultural Forum

Chinese and African officials concluded the China-Africa Agricultural Forum in Beijing on Thursday, which explored possibilities for agricultural cooperation and addressed food security issues, Xinhua reports.

16 Aug 2010

Stockholders of Allscripts, Eclipsys approve fusion of two companies

Allscripts-Misys Healthcare Solutions, Inc. (Allscripts), the leading provider of clinical software, information and connectivity solutions for physicians, and Eclipsys Corporation ,a leading enterprise provider of solutions and services for hospitals and clinicians, today announced that stockholders of each company approved the merger of Allscripts and Eclipsys.

16 Aug 2010

FDA's labeling of Ella as 'Emergency Contraceptive' misleading, says FRC

Today the Food and Drug Administration (FDA) approved Ella, a drug that can cause abortions but is misleadingly labeled as a more effective "Emergency Contraceptive."

16 Aug 2010

Medical News

Exercise can ease arthritis pain

Survey: Majority of U.S. pharmaceutical companies develop drugs for mental illness

Clinical trials activity of Synexus in Hungary increases 25% in first-half of 2010

CTI announces EMEA's validation of expanded PIP for pixantrone

R-Tech Ueno, Sucampo Pharmaceuticals request arbitration against Takeda Pharmaceutical

China Medical Technologies first-quarter fiscal 2010 revenues decrease 10.9% to RMB186.2 million

Washington Hospital's Stroke Program receives Gold Plus Performance Achievement Award

Obama reschedules meeting with state insurance regulators

SAS and EHFCN collaborate to promote awareness on healthcare fraud

Menopause is not the end of women's love life

Northstar Healthcare second-quarter net patient service revenue decreases to $4.4 million

Scientists identify genes associated with aggressive breast cancer

Opinions: PEPFAR funding; Aid in Africa; Obama, human rights

Abnormalities in certain genes may cause autism: Research

Watson to launch ella emergency contraceptive in fourth-quarter 2010

Researchers pace embryonic heart with laser

US WorldMeds announces acquisition of Solstice Neurosciences for $35M

Delegates explore agricultural cooperation, expanded ties at two-day China-Africa Agricultural Forum

Stockholders of Allscripts, Eclipsys approve fusion of two companies

FDA's labeling of Ella as 'Emergency Contraceptive' misleading, says FRC

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Latest News